GAIT results
This article was originally published in The Tan Sheet
Executive Summary
Combination glucosamine/chondroitin sulfate "is effective in treating moderate to severe knee pain due to osteoarthritis," Daniel Clegg, University of Utah, et al., conclude in the Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT). Findings will be presented at the American College of Rheumatology annual meeting in San Diego, Calif. Nov. 14. Authors evaluated 1,583 patients age 40 and older with knee pain of at least six months duration. Participants were randomized to either glucosamine, chondroitin, a glucosamine/chondroitin combination, celecoxib (Pfizer's Celebrex) or placebo for 24 weeks. Authors used WOMAC pain scores to determine the amount of relief experienced by each patient...